Critical care issues in bone marrow transplantation.
Allogeneic bone marrow transplantation (BMT) is an often used therapeutic modality for patients with refractory leukemia as well as for those with other lethal disorders of the lymphohematopoietic system. The extremely high doses of chemotherapy and/or radiation therapy required to prepare patients for BMT, however, render these individuals susceptible to a variety of disorders in the first few months following transplantation. This article reviews the primary causes of nonleukemic mortality in the early post-transplant period.
Brochstein
J A
JA
Bone Marrow Transplantation Service, Memorial Sloan-Kettering Cancer Center, New York, New York.
D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003422:Critical Care; D003520:Cyclophosphamide / Q000009:adverse effects; D006086:Graft vs Host Disease / Q000209:etiology*; D006801:Humans; D007239:Infections / Q000209:etiology; D007938:Leukemia / Q000628:therapy*; D011658:Pulmonary Fibrosis / Q000209:etiology*
D003520:Cyclophosphamide